NCT07385170

Brief Summary

The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Apr 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Apr 2026Apr 2028

First Submitted

Initial submission to the registry

January 27, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 3, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2028

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

January 27, 2026

Last Update Submit

January 27, 2026

Conditions

Cardiac Surgery

Keywords

continuous glucose monitoring

Outcome Measures

Primary Outcomes (1)

  • MARD

    mean absolute relative difference

    From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)

Secondary Outcomes (3)

  • Bland-Altman analysis

    From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)

  • ISO criteria

    From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)

  • DTS error grid

    From the beginning of operation to the end of postoperative ICU stay (maximum 10 days)

Study Arms (1)

CGM cohort

Application of perioperative continuous glucose monitoring

Device: Dexcom G7

Interventions

Dexcom G7DEVICE

Continuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)

CGM cohort

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who scheduled for cardiac surgery in Seoul National University Hospital

You may qualify if:

  • Patients aged 19 years or older scheduled for cardiac surgery

You may not qualify if:

  • Skin disease at the sensor application site (proximal arm)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

Central Study Contacts

Karam Nam, M.D., Ph.D.

CONTACT

+82 2 2072 0643karamnam@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

January 27, 2026

First Posted

February 3, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

April 30, 2028

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

KR(1)